教育背景 |
1991-1995 Bachelor, department of chemistry , Northeast Normal University 1998-2001 Master, Medicinal Chemistry, School of Pharmaceutical Science, Jilin University 2001-2005 Ph.D, Biochemistry and Molecular Biology, School of Pharmaceutical Science, Jilin University |
工作经历 |
2020-, Vice Professor＆Ph.D.supervisor, School of Pharmaceutical, Jilin University; 2009-2019, Vice Professor＆master supervisor, School of Pharmaceutical, Jilin University; 2006-2008, doctor (Ph.D)， Graduate School of Medicine，Akita University, Japan 2002-2009, Lecturer, School of Pharmaceutical, Jilin University; 2001-2002，teaching assistant，School of Basic Medicine， Jilin University; 1995-1998，teaching assistant，School of Basic Medicine，Norman Bethune Medical University |
科研成果 |
1.Yifan Chen, Xiaoping Zhou*.Research progress of mTOR inhibitors[J]. European Journal of Medicinal Chemistry,2020,208:112820 2.Kai Jiang, Xinlin Yan, Jiahao Yu, Zijian Xiao , Hao Wu , Meihua Zhao , Yuandong Yue , Xiaoping Zhou*, Junhai Xiao*, Feng Lin a*.Design, synthesis, and biological evaluation of 3-amino-2- oxazolidinone derivatives as potent quorum-sensing inhibitors of Pseudomonas aeruginosa PAO1[J]. European Journal of Medicinal Chemistry,2020,194:112252 3.Shutao Wang, Muxin Zhang, Di Liang, Wei Sun, Chaozai Zhang, Mengnan Jiang, Junli Liu,Jiaguo Li, Chenchen Li, Xiaohong Yang, Xiaoping Zhou*,Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective,European Journal of Medicinal Chemistry,2019, 175:247-268 4.shen J, Li X, Zhang Z, Luo J, Long H, Tu Z, Zhou X*, Ding K*, Lu X*. 3-amino- pyrazolopyrazine derivatives as spleen tyrosine kinase inhibitors[J]. Chem Biol Drug Des,2016,88(5):690-698 5.Cao FY, Zhou XP*, Su J, Yang XH, Mu FH, Shen JY, Sun W..Chemical Structure Characteristics and Bioactivity of Small Molecule FAK Inhibitors[J].anti-cancer agents in medicinal chemistry, 2016, 16 (8):934-941 |
